BRIEF-Neurovive preclinical data shows substances have inhibitory effect on liver cancer
* Neurovive's new generation of sanglifehrin-based compounds demonstrate potent inhibitory effects on human epatocellular cancer cells [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: inhibitory, cells, epatocellular cancer, human, effects, potent, compounds demonstrate, sanglifehrin-based, generation, Neurovive's, cancer, liver, effect, substances, shows, preclinical, BRIEF-Neurovive
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/3dTKS73AUVw/idUSFWN1FM187